Rx Propellant is a Lifesciences - focused platform that catalyses research, development and manufacturing. Our vision is to propel scientific breakthroughs across all disciplines by establishing world-class clusters. We are part of the Actis portfolio, a leading global investor in sustainable infrastructure, headquartered in London, UK. The Rx Propellant leadership comes with 30+ years’ combined experience in real estate and has been instrumental in conceptualization and development of Genome Valley (GV), Hyderabad as a part of the teams at Ernst & Young (E&Y) and Alexandria Real Estate Inc. What we do? We build world-class Lifesciences clusters by leveraging our expertise in real estate and deep understanding of the Lifesciences domain. We complement infrastructure with a range of ecosystem support services. • Infrastructure: We build state-of-the-art infrastructure tailored to address the needs of our partners. We have five projects in Genome Valley, Hyderabad - Touchstone Square - ARX - Innopolis - Genopolis - Nextopolis Additionally, we have a project in Bengaluru called 'BLR District' and two upcoming projects in Pune and Ahmedabad respectively. Our suite of services ranges from infrastructure development, financing, acquisition, leasing, asset and facility management. • Ecosystem Services - GV Connect: India’s first cluster development enterprise in GV dedicated to promoting the growth of life sciences hubs in India. - GVALS: Genome Valley Academy of Life Sciences (GVALS) is an industry-led skill development initiative that helps bridge academia-industry gap in Life Sciences. - CoLabs: CoLabs is a novel concept of flexi lab spaces for incubating early-stage companies. Website: https://rxpropellant.in/ Contact: info@rxpropellant.in